ã¡ãã£ã¢èšäº
ã¯ã¯ãã³æªæ¥çš®è
ã«ãä¿å¥çšããå°å
¥ãžãã«ããã»ã±ããã¯å·
ããºãææ°ããŒã¯ 195
twitterã³ã¡ã³ã 80ä»¶äž 1ïœ80件
ã€ã¹ã©ãšã«ã®è©±ãšéåéãããã«ãã人ã¯ç¹ç°äœè³ªãªã®ãã®ãïŒ
ðšðŠãè² ããŠãŸããð
çšã眰åãšèããŠããæªããäŸã
ä»äºã¯ã³ããã¯ã¯ãã³ã¯ä»åŸããã¡ãŸãããã匷å¶ããããããªããžã§ãŒã«ãŒã«ãªããããããŸããã
ä»äºã¯ã³ããã¯ã¯ãã³ã¯ä»åŸããã¡ãŸãããã匷å¶ããããããªããžã§ãŒã«ãŒã«ãªããããããŸããã
ã¯ã¯ãã³æªæ¥çš®è
ãžã®å³ããå¶åºŠãã®ãªã·ã£ãã·ã³ã¬ããŒã«ã§ã¯ããã§ã«å®æœãããŠããåçµã¿ãããããã§ãããŒã
ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å
šäœã®ããã12.8ïŒ
ã ããCOVID-19ã§å
¥é¢ããŠããæ£è
ã®ååè¿ããå ããŠãã
ãªãããããŒãªããã
å¥åº·çãªçç±ã§æãŠãªã人ã¯å é€ãããè¯ãã®ã§ã¯
ãªãããããŒãªããã
å¥åº·çãªçç±ã§æãŠãªã人ã¯å é€ãããè¯ãã®ã§ã¯
ãããïŒ
ããæ°ããå¢çš
ã¯ã¯ãã³æã£ãŠãªããšã³ããã¯éçåããããæ²»çè²»ãé«ããªããã¡ãªãã ãããããããŸãã
ã«ãããæ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã«å¯Ÿããä¿å¥çšã課ããšçºè¡š
ã«ãããæ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã«å¯Ÿããä¿å¥çšã課ããšçºè¡š
ãããããªð
ããããã·ã§
æªæ¥çš®è
ã«ãä¿å¥çšããå°å
¥ãž ã«ããã»ã±ããã¯å·
å人çã«ã¯ãçšéãæ²çœ°çã«å°å
¥ããã®ã¯ã©ãããšãæããŸããã
ã¯ã¯ãã³ããæ²»çè¬ã®æ¹ãã³ã¹ããé«ã
æ¥çš®ãã人ãã¡ã¯å¯åå¿ã®äžå®ãä¹ãè¶ããŠæ¥çš®ããŠãã®ã«ãã¢ã¬ã«ã®ãŒä»¥å€ã§æ¥çš®ããªã人ã«ã¯çžå¿ã«è² æ ãããªããš
ã·ã³ã¬ããŒã«ã§ã¯ã¯ã¯ãã³æªæ¥çš®ã§ææã®å Žåå»çè²»ã¯æ¬äººè² æ ãããã
æ¥çš®ãã人ãã¡ã¯å¯åå¿ã®äžå®ãä¹ãè¶ããŠæ¥çš®ããŠãã®ã«ãã¢ã¬ã«ã®ãŒä»¥å€ã§æ¥çš®ããªã人ã«ã¯çžå¿ã«è² æ ãããªããš
ã·ã³ã¬ããŒã«ã§ã¯ã¯ã¯ãã³æªæ¥çš®ã§ææã®å Žåå»çè²»ã¯æ¬äººè² æ ãããã
ããããïœ
ïŒãä»çŸåšã¯ãïŒæ°åãŠã€ã«ã¹å¯Ÿçã®ããã«ïŒäœããã®ç ç²ãæã£ã人å£ã®90ïŒ
ã«ãšã£ãŠãäœãå
¬å¹³ãªã®ããèããæã ãšæããä»åã®ãããªå¯Ÿçãæœã責åããããšæãã
ã¯ã¯ãã³æ¥çš®ã£ãŠç ç²ãªã®ïŒæå³ãããããèªåã®èº«ãå®ãããã®æ¥çš®ãããªãã®ïŒææã¯ããããã ãã
ã¯ã¯ãã³æ¥çš®ã£ãŠç ç²ãªã®ïŒæå³ãããããèªåã®èº«ãå®ãããã®æ¥çš®ãããªãã®ïŒææã¯ããããã ãã
ããããçã£ã瀟äŒãž
æªæ¥çš®è ã«ãä¿å¥çšããå°å ¥ãž ã«ããã»ã±ããã¯å·
æªæ¥çš®è ã«ãä¿å¥çšããå°å ¥ãž ã«ããã»ã±ããã¯å·
ããã¯éåãšçäžå°œã§è¢«äººéçãªæªçœ®ã ãªð¡
éå·æ£è ã®45%ãã¯ã¯ãã³æªæ¥çš®è ã ã£ããšããããä»ã®åæ°ä»¥äžã¯æ¥çš®æžè ã ã£ãã®ã ããéçåçã¯åçã§ã¯ãªãã®ãïŒæ¥çš®æžè ã¯ã¯ã¯ãã³ä»£éãæ¯æã£ããšèšãã®ãïŒæå³ãããããªãð¥Ž
éå·æ£è ã®45%ãã¯ã¯ãã³æªæ¥çš®è ã ã£ããšããããä»ã®åæ°ä»¥äžã¯æ¥çš®æžè ã ã£ãã®ã ããéçåçã¯åçã§ã¯ãªãã®ãïŒæ¥çš®æžè ã¯ã¯ã¯ãã³ä»£éãæ¯æã£ããšèšãã®ãïŒæå³ãããããªãð¥Ž
ã²ã§ããªãæ°äž»åœå®¶ã«ããã¯æ¶ããŸãã
â
â
ã®ãªã·ã£
2021幎12æã1æåã°ä»¥éã«ã¯ã¯ãã³æ¥çš®ãæåŠãã60æ³ä»¥äžã®åžæ°å¯Ÿãã1ã«æããã«100ãŠãŒãïŒçŽ1äž3000åïŒã®çœ°éãç§ããšçºè¡šã
ã·ã³ã¬ããŒã«
ã¯ã¯ãã³ãæã£ãŠããªãç¶æ 㧠ã«ææããå Žåãå»çè²»ãæ¬äººè² æ ã«ãªãã
2021幎12æã1æåã°ä»¥éã«ã¯ã¯ãã³æ¥çš®ãæåŠãã60æ³ä»¥äžã®åžæ°å¯Ÿãã1ã«æããã«100ãŠãŒãïŒçŽ1äž3000åïŒã®çœ°éãç§ããšçºè¡šã
ã·ã³ã¬ããŒã«
ã¯ã¯ãã³ãæã£ãŠããªãç¶æ 㧠ã«ææããå Žåãå»çè²»ãæ¬äººè² æ ã«ãªãã
ãã©ã³ãœã¯ã»ã«ãŽãŒå·éŠçž
1åç®ã®ã¯ã¯ãã³æ¥çš®ãçµããŠããªã人ã¯ãè² æ éããæ¯æãããšã«ãªãã
éé¡ã¯ãŸã 決ãŸã£ãŠããªããããå€é¡ãã«ãªãã ãã
1åç®ã®ã¯ã¯ãã³æ¥çš®ãçµããŠããªã人ã¯ãè² æ éããæ¯æãããšã«ãªãã
éé¡ã¯ãŸã 決ãŸã£ãŠããªããããå€é¡ãã«ãªãã ãã
å
¬å¹³ã§å€§è³æã§ãã
ã¯ã¯ãã³æ¥çš®è ã¯åã¯ã¯ãã³è«è ã®ããããªã¹ã¯ãããšã£ãŠããã®ã§ãããã
圌ãã«å»çè³æºãè²»ããããŠããã¢ã¡ãªã«ã§ãå³å»æ€èšããŠã¬ã³ã¬ã³åŸŽåããŠã»ããã§ãããããŠåŸŽåéããšãã»ã³ã·ã£ã«ã¯ãŒã«ãŒãžã®ãµããŒãã«äœ¿ã£ãŠã»ããïŒ
ã¯ã¯ãã³æ¥çš®è ã¯åã¯ã¯ãã³è«è ã®ããããªã¹ã¯ãããšã£ãŠããã®ã§ãããã
圌ãã«å»çè³æºãè²»ããããŠããã¢ã¡ãªã«ã§ãå³å»æ€èšããŠã¬ã³ã¬ã³åŸŽåããŠã»ããã§ãããããŠåŸŽåéããšãã»ã³ã·ã£ã«ã¯ãŒã«ãŒãžã®ãµããŒãã«äœ¿ã£ãŠã»ããïŒ
ãããŸã§ãããéçåäºé²ãã«ã®ã¿çç®ãããã¹ããŒãéçšãªã®ã§ãå®éã®çŸè±¡ãšéçšãäžèŽããŠãã®ã§æšããã
æ¥æ¬ã§ãããªããå»çè²»è² æ å²åãå¥åº·ä¿éºã®è² æ ãðã®æç¡ãåæ¡ããŠãªã¹ã¯é«ãæ¹ãå¢ããã£ãŠåœ¢ã«ãªãã®ããªãããžã§æãŠãªãå Žåãé€ããŠã
æ¥æ¬ã§ãããªããå»çè²»è² æ å²åãå¥åº·ä¿éºã®è² æ ãðã®æç¡ãåæ¡ããŠãªã¹ã¯é«ãæ¹ãå¢ããã£ãŠåœ¢ã«ãªãã®ããªãããžã§æãŠãªãå Žåãé€ããŠã
ãã«ã¿èªç©ºã¿ããã«ä¿éºæäžä¹ãã ãã§ãªãã解éãŸã§è³ã£ããã
ãªã¹ã¯èããæ«ã®æ±ºæãªã®ããªã
ãŸããå·åäœã§ä¿éºæäžä¹ããããæ¹éã®åœãåºãŠããããª
ãªã¹ã¯èããæ«ã®æ±ºæãªã®ããªã
ãŸããå·åäœã§ä¿éºæäžä¹ããããæ¹éã®åœãåºãŠããããª
ãã±ããã¯å·ã¯ãã«ããã§ãç¹ã«æ°åãŠã€ã«ã¹ã®æ»è
ãå€ããçŸåšãæææ¡å€§ã«èŠæ
®ããŠãããã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å
šäœã®ããã12.8ïŒ
ã ããCOVID-19ã§å
¥é¢ããŠããæ£è
ã®ååè¿ããå ããŠãããšãããã
ã»ãïŒæ¬§ç±³ãèŠç¿ããªããšïŒ
ãã®ãªã·ã£ã¯æšå¹Ž12æã1æåã°ä»¥éã«ã¯ã¯ãã³æ¥çš®ãæåŠãã60æ³ä»¥äžã®åžæ°å¯Ÿãã1ã«æããã«100ãŠãŒãïŒçŽ1äž3000åïŒã®çœ°éãç§ããšçºè¡šããïŒ
ãã©ã³ãœã¯ã»ã«ãŽãŒå·éŠçžã¯ãéé¡ã¯ãŸã 決ãŸã£ãŠããªããããå€é¡ãã«ãªãã ããããšè©±ãã
å€é¡ïŒ
å€é¡ïŒ
ä»ã®åœã¯ç¥ãããã«ãããªãçŽåŸãããããåœã ããªã
è幎ã¯å
ã«ã¯ðð°å€§å€ãã è±å
ã®åŠããŽãããŽãããšã¯ðŠNightæéè¿«ã
ð¬ð·ã矩åã«ãªãããããã³ãã€ãã³çç±ãã¡ãããšå ±éããŠããã®ãïŒæç¥ã®ææå°å³åŒçšããç·šéãåŒçšããŠãæç¥æå³éãä¿
ð¬ð·ã矩åã«ãªãããããã³ãã€ãã³çç±ãã¡ãããšå ±éããŠããã®ãïŒæç¥ã®ææå°å³åŒçšããç·šéãåŒçšããŠãæç¥æå³éãä¿
åã¯ã¯ãã³çšãâŠ
ããžã§ïŒ
æ¥æ¬ã«ãå°å
¥ããŠæ¬²ããã
å ¥é¢è ã®ã»ãšãã©ãæªæ¥çš®ã ããããã€ãã®å»çè²»ã俺ãã«è² æ ããªãã§ã
å ¥é¢è ã®ã»ãšãã©ãæªæ¥çš®ã ããããã€ãã®å»çè²»ã俺ãã«è² æ ããªãã§ã
ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å
šäœã®ããã12.8ïŒ
ã ããCOVID-19ã§å
¥é¢ããŠããæ£è
ã®ååè¿ããå ããŠãããšããã
ã²ããã
ïŒä»åœã®äŸãŒèšäºããïŒ
ã®ãªã·ã£âã¯ã¯ãã³æ¥çš®ãæåŠãã60æ³ä»¥äžã®åžæ°ã«1ã«æããã«100ãŠãŒãã®çœ°é
ã·ã³ã¬ããŒã«âã¯ã¯ãã³ãæã£ãŠããªãç¶æ ã§ææãããå»çè²»æ¬äººè² æ
âŒ
ïŒä»åœã®äŸãŒèšäºããïŒ
ã®ãªã·ã£âã¯ã¯ãã³æ¥çš®ãæåŠãã60æ³ä»¥äžã®åžæ°ã«1ã«æããã«100ãŠãŒãã®çœ°é
ã·ã³ã¬ããŒã«âã¯ã¯ãã³ãæã£ãŠããªãç¶æ ã§ææãããå»çè²»æ¬äººè² æ
âŒ
æ¥æ¬ãç¹å¥ãªäºæ
ããªããã°ã³ã¬ããâŠ
銬鹿ãªäºãâŠ
ããã«ãã«ããã®é²æ¬¡éããããããªããšã§ããã
âã«ããïŒã±ããã¯å·ãã¯ã¯ãã³æªæ¥çš®è
ã«ïœ¢ä¿å¥çšïœ£å°å
¥ãçºè¡š
åå·ã¯æææ¡å€§äžã§ãããã¯ã¯ãã³æªæ¥çš®ã¯äœæ°ã®12%ã«å¯ŸããCOVID-19å ¥é¢è æ°ã®åæ°è¿ããå ãããšã
ICUæ£è ã®45%ãã¯ã¯ãã³æªæ¥çš®ã
11æ¥ã«ã¯62人ãæ»äº¡ããã¯ã¯ãã³æ¥çš®ãå§ãŸãåã®æ°Žæºã«äžæã
åå·ã¯æææ¡å€§äžã§ãããã¯ã¯ãã³æªæ¥çš®ã¯äœæ°ã®12%ã«å¯ŸããCOVID-19å ¥é¢è æ°ã®åæ°è¿ããå ãããšã
ICUæ£è ã®45%ãã¯ã¯ãã³æªæ¥çš®ã
11æ¥ã«ã¯62人ãæ»äº¡ããã¯ã¯ãã³æ¥çš®ãå§ãŸãåã®æ°Žæºã«äžæã
ãããŸã§ããŸãã
ã¯ã¯ãã³æªæ¥çš®è
ã«
ãä¿å¥çšããå°å ¥ãž
ã«ããã»ã±ããã¯å·(BBC News)
ãä¿å¥çšããå°å ¥ãž
ã«ããã»ã±ããã¯å·(BBC News)
ïŒã«ããã»ã±ããã¯å·ã¯ã¯ã¯ãã³æªæ¥çš®è
ã«ä¿å¥çšã課ãïŒ
ä»çŸåšã¯ã(æ°åãŠã€ã«ã¹å¯Ÿçã®ããã«)äœããã®ç ç²ãæã£ã人å£ã®90ïŒ ã«ãšã£ãŠãäœãå ¬å¹³ãªã®ããèããæã ãšæãã
ä»åã®ãããªå¯Ÿçãæœã責åããããšæãã
ïŒãã©ã³ãœã¯ã»ã«ãŽãŒå·éŠçžïŒ
ä»çŸåšã¯ã(æ°åãŠã€ã«ã¹å¯Ÿçã®ããã«)äœããã®ç ç²ãæã£ã人å£ã®90ïŒ ã«ãšã£ãŠãäœãå ¬å¹³ãªã®ããèããæã ãšæãã
ä»åã®ãããªå¯Ÿçãæœã責åããããšæãã
ïŒãã©ã³ãœã¯ã»ã«ãŽãŒå·éŠçžïŒ
æ¥æ¬ã§ã¯çµ¶å¯Ÿåºæ¥ãªãããâŠ
å»çè²»ãå
¬è²»ã§è³ãããŠãããªã劥åœãªèœãšãã©ããããšã
æ¥æ¬ãæ©ãïŒïŒ
[ã¿ã¬]ã±ããã¯å·ãã¯ã¯ãã³æªæ¥çš®è
ãžã®ãå¥åº·çšãã®å°å
¥ãçºè¡š ã±ããã¯å·ã§ã¯ã¯ã¯ãã³æªæ¥çš®è
ã人å£ã®10%ã«ãé¢ããããéäžæ²»ççšã®ç
åºã®50%ãå ããŠãããšã®ããšã§ããããã®äººã
ãä»ã®ã±ããã¯å·æ°ã«éãééçéè·ãèè² ãããŠããããšã
ããä»çŸåšã¯ãïŒæ°åãŠã€ã«ã¹å¯Ÿçã®ããã«ïŒäœããã®ç ç²ãæã£ã人å£ã®90ïŒ
ã«ãšã£ãŠãäœãå
¬å¹³ãªã®ããèããæã ãšæããä»åã®ãããªå¯Ÿçãæœã責åããããšæããã
ã·ã³ã¬ããŒã«ã§ã¯ãã¯ã¯ãã³ãæã£ãŠããªãç¶æ
ã§æ°åãŠã€ã«ã¹ã«ææããå Žåãå»çè²»ãæ¬äººè² æ
ã«ãªãã
ãã®ãããã¯æ¥æ¬ããã£ãæ¹ã
ãã®ãããã¯æ¥æ¬ããã£ãæ¹ã
ã«ããã±ããã¯å·ã§ã¯
æªæ¥çš®ã¯12.8ïŒ ã ã
COVID-19ã§å ¥é¢ããŠãã
æ£è ã®ååè¿ããå ããŠããã
æªæ¥çš®ã¯12.8ïŒ ã ã
COVID-19ã§å ¥é¢ããŠãã
æ£è ã®ååè¿ããå ããŠããã
ãåœéãã¥ãŒã¹ã®ããŒã¿ã«ãµã€ãã âŠ
ãã®æããã£ããã
ã¯ã¯ãã³å©æš©åŽãå¥åº·ãªåœæ°ãå®ãçºã«äŒæ¥åŽã«å°å
¥ããã¹ããã®ã§ãã±ããã¯ã¯ã¯ã¯ãã³å©æš©ãæ¯é
è
åŽã«å©ããããã«å€§è¡ã«å§åããããŠããŸãã
ãããããæªæ¥çš®è
ãžã®ããããå³ãããšãããšããã§ãªããšãããããããã©ããã
ã³ããã®ç·æ»äº¡è
æ°ãå®éã¯1/100以äž(ãã«ãã¬ã«)ãå£ç¯æ§ã€ã³ãã«ãšã³ã¶æ»äº¡è
æ°ããå°ãªãããã€ã¯ã¯ãã³ã®è¬å®³æ§ãç¡èŠããŠãããé節ãªå¯äœçšã§èŠããã§ãã人ãæ¥çš®åŸã«äº¡ããªã£ããå
æ°ã ã£ãå€ãã®äººéãžã®åæ¶ã
ããã¯ããéããšæã£ããã©ãæªæ¥çš®è
12.8%ã§ãCOVID-19ã§å
¥é¢ããŠããæ£è
ã®ååè¿ããå ããã
ã¯ã¯ãã³ã¯2åè«žçµè²»åãããŠ\5,000çšåºŠã§ãç±³åœã®å ŽåãCOVID-19ã§å ¥é¢ããå Žåã®æ²»çè²»ã¯å¹³å833äžåã
å ¥é¢è²»ã¯ããåœã®äºæ ã§éããšããŠãæ°çŸäžã¯æããã
ã¯ã¯ãã³ã¯2åè«žçµè²»åãããŠ\5,000çšåºŠã§ãç±³åœã®å ŽåãCOVID-19ã§å ¥é¢ããå Žåã®æ²»çè²»ã¯å¹³å833äžåã
å ¥é¢è²»ã¯ããåœã®äºæ ã§éããšããŠãæ°çŸäžã¯æããã
4æéå
ã¢ã¡ãªã«ãããããã¹ãã
åœç¶ã ããã«ããâŠå»çã³ã¹ããããããã§ããã«ã
> 身äœççç±ä»¥å€ã®ã¯ã¯ãã³æªæ¥çš®è
ãææããå Žåã¯å¿åã®æ²»çè²»è² æ
ãæ±ãã
> ãšããã®ã¯äžççãªæµãã«ãªããã
>
> >
> ãšããã®ã¯äžççãªæµãã«ãªããã
>
> >
ãããæ¥æ¬ããããšè¯ããã >
ã»ã»ã»ã«ãã æ²æšãªäºã«ãªã£ãŠãããçæ°ã
è
ã«
ã ããå°å ¥ãž
ã«ããã»ã±ããã¯å·
æ¥æ¬ã®ãã«æ¿åºã
å®æã«ç䌌ãããã§æãã
ã ããå°å ¥ãž
ã«ããã»ã±ããã¯å·
æ¥æ¬ã®ãã«æ¿åºã
å®æã«ç䌌ãããã§æãã
ã¯ã¯ãã³æ¥çš®ããŠãã人ãææãä»ã®äººãžãã€ããŠããã®ã¯äºå®ãã¯ã¯ãã³æ¥çš®ããŠããªã人ã«ã ãçšãç§ãã®ã¯ãééããçã ããäºã ãšæããªãå·ããããã ãªãã¯ã¯ãã³æ¥çš®ãããã°ããã»ã©å
ç«äœäžã«ãªã£ãŠææããããèš³ãªã®ã«ãã
éã«éãæãã°èš±ããããã®ãªã®ãïŒ
ããã¯åçŽã«è³ç£ãæããªã人éãžã®æ¥çš®åŒ·å¶ã ãã
ããã¯åçŽã«è³ç£ãæããªã人éãžã®æ¥çš®åŒ·å¶ã ãã
ãåœéãã¥ãŒã¹ã®ããŒã¿ã«ãµã€ãã âŠ
ãïŒããããã
æ¥æ¬ãå°å ¥ã¯ãwww
æ¥æ¬ãå°å ¥ã¯ãwww
æªæ¥çš®è
ã«ãéãåããã¯è¯ããã©
éã«ã¯ã¯ãã³æ¥çš®ããŠåŸéºçãç æ° äœã®äžèª¿ãããã°
åœãããéãããã®ïŒ
ããŒããªããšèšã£ãŠãäºã«äžå ¬å¹³ã ãã
éã«ã¯ã¯ãã³æ¥çš®ããŠåŸéºçãç æ° äœã®äžèª¿ãããã°
åœãããéãããã®ïŒ
ããŒããªããšèšã£ãŠãäºã«äžå ¬å¹³ã ãã
ïŒã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å
šäœã®ããã12.8ïŒ
ã ããCOVID-19ã§å
¥é¢ããŠããæ£è
ã®ååè¿ããå ããŠãããšããã
ã眰éãã§ã¯ãªããŠããã¯ãæªæ¥çš®è å士ã®å ±å©ãããšâŠ
ã眰éãã§ã¯ãªããŠããã¯ãæªæ¥çš®è å士ã®å ±å©ãããšâŠ
身äœçãªäºæ
ã§æãŠãªã人ã¯ãããããã ãªãšããæ°ã¯ãããã
1åç®ã®ã¯ã¯ãã³æ¥çš®ãçµããŠããªã人ã¯ãè² æ
éããæ¯æãããšã«ãªããšèª¬æãéé¡ã¯ãŸã 決ãŸã£ãŠããªããããå€é¡ãã«ãªãã ãããšè©±ããã
éæ¥çš®è
ã¯æ¥çš®è
ãšæ¯èŒããéçåããå¯èœæ§ãé«ãã®ã§ãç
åºãå§è¿«ãããããå»çè²»ãé«ããªã£ãŠããŸãããããã®ãæäžããã¯ãããããªãããšãªãšæã
å¢çšå€§å¥œã岞ç°ããåºçªã§ããïŒç¬ïŒ
å¢çšå€§å¥œã岞ç°ããåºçªã§ããïŒç¬ïŒ
ãã«ããã®ã±ããã¯å·ã¯11æ¥ãæ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã«å¯Ÿããä¿å¥çšã課ããâææãªã¹ã¯ãé«ã人ã¯âä¿éºæãé«ãâãšãã話ã ãã矩ååãé¿ãã€ã€åŠ¥åœãªæœçã ãšæãã
æ¥æ¬ããã
å»çè²»å šé¡èªè²»ã§ãããã
å»çè²»å šé¡èªè²»ã§ãããã
ãã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å
šäœã®ããã12.8ïŒ
ã ããCOVID-19ã§å
¥é¢ããŠããæ£è
ã®ååè¿ããå ããŠãããšããã...ã£ãŠäºã¯æ®ãã®æ£è
ã¯æ¥çš®æžã£ãŠè©±ã
æžãæ¹ãªãã ããªãŒð
æžãæ¹ãªãã ããªãŒð
åå·ã§ã¯ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å
šäœã®ããã12.8ïŒ
ã ããCOVID-19ã§å
¥é¢ããŠããæ£è
ã®ååè¿ããå ããŠãã
â
ã€ã¥ã
å·éŠçžã¯ã1åç®ã®ã¯ã¯ãã³æ¥çš®ãçµããŠããªã人ã¯ãè² æ éãïŒä¿å¥çšïŒãæ¯æãããšã«ãªããšèª¬æã
ã€ã¥ã
å·éŠçžã¯ã1åç®ã®ã¯ã¯ãã³æ¥çš®ãçµããŠããªã人ã¯ãè² æ éãïŒä¿å¥çšïŒãæ¯æãããšã«ãªããšèª¬æã
âããã¯ããããªãã§ããšã¯æãããåœã®èšããªããšããäºã§ã¯ãªãããã®åã«èªäž»çã«ã¯ã¯ãã³æ¥çš®ããããšäœæ
æããªãã®ãããâŠã
ããã«ã¯å²žç°ç·çãããã³ãª
æªæ¥çš®çš
ããã¯æ¥æ¬ã§ãè¡ãããã§ããã
ããã¯ããããªå¢çšããããšã¯ããŠã€ã«ã¹ã«ã€ããŠã¯ç¡ç¥ã§ããæªç¥æµã¯åããŸãã
財åçãå°ãã€ãããã§ã
æªæ¥çš®å¢çšãæªæ¥çš®ãåããè·æ¥ã®éå®ãªã©
ãããã§ãã§ãããã§ãã
æ²æ³ïŒäœããïŒã£ãŠæãã§ãã
ããã¯æ¥æ¬ã§ãè¡ãããã§ããã
ããã¯ããããªå¢çšããããšã¯ããŠã€ã«ã¹ã«ã€ããŠã¯ç¡ç¥ã§ããæªç¥æµã¯åããŸãã
財åçãå°ãã€ãããã§ã
æªæ¥çš®å¢çšãæªæ¥çš®ãåããè·æ¥ã®éå®ãªã©
ãããã§ãã§ãããã§ãã
æ²æ³ïŒäœããïŒã£ãŠæãã§ãã
ã¡ã¢
ããããç¶æ³ã§ãçºããåããããšãããšãããã
"ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å šäœã®ããã12.8ïŒ ã ããCOVID-19ã§å ¥é¢ããŠããæ£è ã®ååè¿ããå ããŠãããšãã"
ããããç¶æ³ã§ãçºããåããããšãããšãããã
"ã¯ã¯ãã³ãæã£ãŠããªãäœæ°ã¯å šäœã®ããã12.8ïŒ ã ããCOVID-19ã§å ¥é¢ããŠããæ£è ã®ååè¿ããå ããŠãããšãã"
ã¯ã¯ãã³æããªããçšéãšãããð°